Edinburgh Clinical Trials

HighSTEACS

High-sensitivity Troponin in the Evaluation of patients with Acute Coronary Syndrome (HighSTEACS): A randomised controlled trial

The aim is to determine whether lowering the diagnostic threshold for myocardial infarction using a novel high-sensitivity cardiac troponin assay will improve outcomes in patients with suspected acute coronary syndrome.
 
Chief Investigator: Prof Nicholas Mills
Number and location of participating sites (by region/ country): 10 sites across NHS Lothian and NHS Greater Glasgow & Clyde, Scotland
ClinicalTrials.gov Identifier NCT01852123 http://clinicaltrials.gov/ct2/show/NCT01852123
 
Funder: British Heart Foundation
Start and End date of grant award:  October 2012 – October 2017
 
Current Status: Completed and Published at https://doi.org/10.1016/S0140-6736(18)31923-8
Protocol:
Statistical Analysis Plan:
 
GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with GDPR, please read this document.
 
Contact details

Sponsor: University of Edinburgh, NHS Lothian Health Board ACCORD

Chief Investigator: Professor Nicholas Mills, Room SU225, Chancellor's Building, University of Edinburgh, Royal Infirmary, Little France, Edinburgh, EH16 4SB, UK

Clinical Research Manager: Fiona Strachan

Trial Manager: Chris Tuck

 
ECTU Involvement : Trial management / Statistics/ Database
(UKCRC)
 
HighSTEACS logo